13,454
Total Claims
$2.5M
Drug Cost
4,357
Beneficiaries
$581
Cost/Patient
Peer Comparison vs. 218,535 Nurse Practitioner providers
-97%
Opioid rate vs peers
0.1% vs 3.8% avg
-50%
Cost per patient vs peers
$581 vs $1,174 avg
+43%
Brand preference vs peers
12.7% vs 8.9% avg
Opioid Prescribing
0.1%
Opioid Rate
15
Opioid Claims
$73
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
87% generic
Brand: 1,701 claims · $2.0M
Generic: 11,720 claims · $503K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Mirabegron | 933 | $655K |
| Vibegron | 427 | $311K |
| Enzalutamide | 17 | $247K |
| Apalutamide | 13 | $196K |
| Tamsulosin Hcl | 4,276 | $94K |
| Silodosin | 202 | $37K |
| Testosterone | 86 | $35K |
| Finasteride | 1,812 | $34K |
| Tadalafil | 87 | $31K |
| Methenamine Hippurate | 266 | $29K |
| Trospium Chloride | 416 | $29K |
| Solifenacin Succinate | 379 | $27K |
| Trospium Chloride | 104 | $26K |
| Onabotulinumtoxina | 26 | $26K |
| Oxybutynin Chloride | 671 | $22K |
Prescribing Profile
55
Unique Drugs
Patient Profile
75
Avg Age
23%
Female
1.28
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data